Q2 2019 Holdings
Filed 2019-08-14 | 31 holdings | $900.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Iovance Biotherapeutics, Inc.(IOVA) | COM | 462260100 | $129.0M | 5,260,803 | 14.3% |
| PTC Therapeutics, Inc.(PTCT) | COM | 69366J200 | $88.8M | 1,974,385 | 9.9% |
| Zogenix, Inc. | COM | 98978L204 | $76.1M | 1,593,396 | 8.5% |
| Audentes Therapeutics, Inc.(BOLDEUR) | COM | 05070R104 | $72.8M | 1,922,937 | 8.1% |
| Kura Oncology, Inc.(KURA) | COM | 50127T109 | $60.0M | 3,047,800 | 6.7% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $59.5M | 1,449,300 | 6.6% |
| Ascendis Pharma AS(ASND) | SPOSORED ADR | 04351P101 | $57.6M | 500,000 | 6.4% |
| Tricida, Inc.(1T7) | COM | 89610F101 | $56.2M | 1,423,998 | 6.2% |
| Acadia Pharmaceuticals, Inc.(ACAD) | COM | 004225108 | $40.1M | 1,500,000 | 4.5% |
| Mirati Therapeutics Inc.(MRTXEUR)Put | COM | 60468T105 | $30.9M | 300,000 | 3.4% |
| Mirati Therapeutics Inc.(MRTXEUR) | COM | 60468T105 | $30.9M | 300,000 | 3.4% |
| Zymeworks Inc. | COM | 98985W102 | $23.4M | 1,064,041 | 2.6% |
| Retrophin Inc. | COM | 761299106 | $20.2M | 1,003,600 | 2.2% |
| Miratii Therapeutics Inc.(MRTXEUR)Call | COM | 60468T105 | $18.0M | 175,000 | 2.0% |
| Prothena Corporation PLC(PRTA) | COM | G72800108 | $17.7M | 1,676,250 | 2.0% |
| Biohaven Pharmaceutical Holding Co Ltd.(BHVN) | COM | G11196105 | $15.3M | 350,000 | 1.7% |
| Millendo Therapeutics, Inc. | COM | 60040X103 | $14.9M | 1,288,093 | 1.7% |
| Dermira Inc.(DERMEUR) | COM | 24983L104 | $14.8M | 1,552,900 | 1.6% |
| Zogenix, Inc.Put | COM | 98978L204 | $14.3M | 300,000 | 1.6% |
| Genfit | ADS | 372279109 | $13.7M | 694,253 | 1.5% |
| Menlo Therapeutics Inc. | COM | 586858102 | $10.4M | 1,733,882 | 1.2% |
| Biohaven Pharmaceutical Holding Co. Ltd.(BHVN)Put | COM | G11196105 | $8.8M | 200,000 | 1.0% |
| Foamix Pharmaceuticals LTD | COM | M46135105 | $5.0M | 2,110,071 | 0.6% |
| Iovance Biotherapetuics, Inc.(IOVA)Call | COM | 462260100 | $4.9M | 200,000 | 0.5% |
| Momenta Pharmaceuticals, Inc.(MNTA) | COM | 60877T100 | $4.3M | 342,064 | 0.5% |
| Osmotica Pharmaceuticals PLC | COM | G6S41R101 | $3.5M | 926,933 | 0.4% |
| Proteostasis Therapeutics Inc. | COM | 74373B109 | $3.4M | 3,500,000 | 0.4% |
| Five Prime Therapeutics, Inc.(FPRX) | COM | 33830X104 | $3.3M | 547,712 | 0.4% |
| Zafgen Inc. | COM | 98885E103 | $2.6M | 2,211,194 | 0.3% |
| Streamline Health Solutns, Inc. | COM | 86323X106 | $197.0K | 130,137 | 0.0% |